Impact of obesity on children undergoing liver transplantation

Liver Transplantation

Volumn 16, Issue 11, 2010, Pages 1296-1302

  Dick, André A S ^a   Perkins, James D ^a   Spitzer, Austin L ^b   Lao, Oliver B ^a   Healey, Patrick J ^c   Reyes, Jorge D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Oakland Medical Center   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; KAPLAN MEIER METHOD; LIVER TRANSPLANTATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; CHILD; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; THINNESS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78349283464     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22162     Document Type: Article

References (25)

1. World Health Organization. Global strategy on diet, physical activity and health. Accessed July 2010.
2. National Center for Health Statistics. Prevalence of overweight among children and adolescents: United States, 2003-2004. Accessed July 2010.
3. Dick AA, Spitzer AL, Seifert CF, Deckert A, Carithers RL Jr, Reyes JD, et al. Liver transplantation at the extremes of body mass index. Liver Transpl 2009; 15: 968 - 977.
4. Flancbaum L, Choban PS., Surgical implications of obesity. Annu Rev Med 1998; 49: 215 - 234.
5. Choban PS, Flancbaum L., The impact of obesity on surgical outcomes: a review. J Am Coll Surg 1997; 185: 593 - 603.
6. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C., Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388 - 1393.
7. Thuluvath PJ., Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation. Liver Transpl 2007; 13: 1627 - 1629.
8. Pelletier SJ, Schaubel DE, Wei G, Englesbe MJ, Punch JD, Wolfe RA, et al. Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl 2007; 13: 1678 - 1683.
9. Nair S, Verma S, Thuluvath PJ., Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002; 35: 105 - 109.
10. Sawyer RG, Pelletier SJ, Pruett TL., Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999; 13: 126 - 130.
11. Hanevold CD, Ho PL, Talley L, Mitsnefes MM., Obesity and renal transplant outcome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2005; 115: 352 - 356.
12. World Health Organization. Growth reference data for 5-19 years. Accessed July 2010.
13. Mitsnefes MM, Khoury P, McEnery PT., Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol 2002; 17: 535 - 539.
14. Ode KL, Frohnert BI, Nathan BM., Identification and treatment of metabolic complications in pediatric obesity. Rev Endocr Metab Disord 2009; 10: 167 - 188.
15. Rosenbloom AL, Joe JR, Young RS, Winter WE., Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345 - 354.
16. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802 - 810.
17. Freedman DS, Khan LK, Serdula MK, Dietz WH, Sriinivasan SR, Berenson GS., The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics 2005; 115: 22 - 27.
18. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, et al. Body mass index and risk, age of onset and survival in patients with pancreatic cancer. JAMA 2009; 301: 2553 - 2562.
19. Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ., Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl 2009; 15: 1662 - 1670.
20. Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109 - 1114.
21. Munoz SJ, Elghenaidi H., Cardiovascular risk factors after liver transplantation. Liver Transpl 2005; 11 (suppl 2): S52 - S56.
22. Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004; 114: 217 - 223.
23. Menegazzo LA, Ursich MJ, Fukui RT, Rocha DM, Silva ME, Ianhez LE, et al. Mechanism of the diabetogenic action of cyclosporin A. Horm Metab Res 1998; 30: 663 - 667.
24. Vincenti F, Tuncer M, Castagneto M, Klinger M, Friman S, Scheuermann EH, et al. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. Transplant Proc 2005; 37: 1001 - 1004.
25. Van Duijnhoven EM, Christiaans MH, Boots JM, Nieman FH, Wolffenbuttel BH, van Hooff JP., Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol 2002; 13: 213 - 220.